Combination of regorafenib and anti-PD-1: Effective against fibrotic tumors (IMAGE)

Kumamoto University

Combination of regorafenib and anti-PD-1: Effective against fibrotic tumors

Caption

Regorafenib works synergistically with immune checkpoint inhibitors to markedly reduce tumor fibrosis in advanced gastric cancers.

Credit

Takatsugu Ishimoto from Kumamoto University

Usage Restrictions

Reproductions of this image should include a reference to this release.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.